If this box remains here for more than 30 seconds, click this link to try again.
Products & Services »
Best Practice Database
Clinical Operations » Clinical Budgets and Staffing
Download FREE Excerpt
19 Info Graphics
27 Data Graphics
Single User: Authorizes use by the person who places the order or for whom the order was placed.
Sitewide: Authorizes use of the report for a geographic site. All people at site can view the report for a year and copies can be printed.
Corporate: Authorizes use for the entire company for a year and copies can be printed. No limitations for usage inside the company.
Clinical programs at medical device organizations are increasingly looking to less expensive and regulated areas of the world to perform clinical trial activities. Emerging markets are also fast-growing regions that present future growth opportunities for organizations that have seen sales growth slow in mature markets.
However, there are still questions around the cost, quality and pitfalls of conducting clinical trials in emerging regions.
Best Practices®, LLC conducted this study to inform clinical affairs leaders at medical device companies on benchmarks around budgets, and staffing. In addition, the study presents benchmarks and insights around the current level of clinical trials in emerging areas, the cost and quality of outside-U.S. trials, and outsourcing levels for key clinical activities.
Critical outsourcing questions addressed in this survey include:
Research participants included 13 executives and managers from 11 medical device companies across a wide variety of therapeutic areas and product classes. In addition, four in-depth interviews were conducted to capture innovative practices in clinical activities in emerging areas.
Diagnostic; Health Care; Medical Device; Orthopaedics; Medical
Abbott Vascular; Medrad; Medtronic; Boston Scientific; BARD; Zimmer; St. Jude Medical; Smith & Nephew; Stryker; Teleflex; Covidien